Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | m-Chloroperbenzoic acid | HCID 70297 | — |
| Reactant | HCID 23115895 | HCID 23115895 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 23115886 | HCID 23115886 | — |
Reaction Steps
To a solution of 3-[3-(methylsulfanyl)phenyl]-6-piperidin-1-yl-1,2,4-triazolo[4,3-b]pyridazine (550 mg) in methylene chloride (30 ml), 3-chloroperbenzoic acid (1.25 g) was added at room temperature, and the mixture was stirred for 13 hours. The reaction solution was combined with water, and diluted with methylene chloride. The organic phase washed successively with water, 1M aqueous solution of sodium hydroxide and brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resultant residue was purified by silica gel column chromatography (eluent:chloroform:methanol=98:2) and washed with ethanol to obtain 3-[3-(methylsulfonyl)phenyl]-6-piperidin-1-yl-1,2,4-triazolo[4,3-b]pyridazine (250 mg) as colorless crystals.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07173033B2 |
|---|
| Source dataset | uspto-grants-2007_02 |
|---|
| ORD ID | ord-dd6074396acf48eab18ec35d62eebf52 |
|---|
| Source note | uspto-grants-2007_02 |
|---|